The quantum computing company will likely remain a volatile stock this year.

D. Boral and ARC Group Further Strengthen SPAC Leadership and Global Presence with a Series of SPAC IPOs Beginning in 2025 ...

Partnership Combines VERAXA's Proprietary ADC Technology with OmniAb's Antibody Discovery Technology for Novel Therapies Targeting Solid TumorsZURICH, SWITZERLAND, May 5, 2025 -- VERAXA Biotech AG(NAS ...

It is difficult to find another instance where a leading corporate that commands a market value of approximately Rs2.5tn ...